Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here is what I think is a real possibility

But Fut, if there were DEFINITE monies forthcoming, though in unknown/TBD amounts, wouldn't this HAVE TO be stated in some fashion in the 10Q?

This point is exactly what leads me down the "contingency path".  In that scenario, nothing is absolute/definite, and therefore nothing would have to be said in the 10Q, IMO.

IMO, in any royalty scenario, something would have to be reported.

Do you now opine otherwise (as I believe you suggested what I'm saying in the past, re: royalties in the customary sense - not a one-time payment and based on sales or something)?

SGE

Share
New Message
Please login to post a reply